Reducing sarcolipin expression mitigates Duchenne muscular dystrophy and associated cardiomyopathy in mice
Sarcolipin is an inhibitor of the ATP dependent calcium pump SERCA, and is abnormally elevated in Duchenne muscular dystrophy. The authors show that reducing sarcolipin expression ameliorates skeletal muscle pathology and cardiomyopathy and extends life span in mouse models of DMD.
Guardado en:
Autores principales: | Antanina Voit, Vishwendra Patel, Ronald Pachon, Vikas Shah, Mohammad Bakhutma, Erik Kohlbrenner, Joseph J. McArdle, Louis J. Dell’Italia, Jerry R. Mendell, Lai-Hua Xie, Roger J. Hajjar, Dongsheng Duan, Diego Fraidenraich, Gopal J. Babu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/201501e20c1241caab7a1010c329171a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Computer task performance by subjects with Duchenne muscular dystrophy
por: Malheiros SRP, et al.
Publicado: (2015) -
Current and emerging treatment strategies for Duchenne muscular dystrophy
por: Mah JK
Publicado: (2016) -
Evidence for ACTN3 as a genetic modifier of Duchenne muscular dystrophy
por: Marshall W. Hogarth, et al.
Publicado: (2017) -
24 month longitudinal data in ambulant boys with Duchenne muscular dystrophy.
por: Elena Stacy Mazzone, et al.
Publicado: (2013) -
Evaluation of muscular changes by ultrasound Nakagami imaging in Duchenne muscular dystrophy
por: Wen-Chin Weng, et al.
Publicado: (2017)